C
Craig A. Clifford
Researcher at University of Pennsylvania
Publications - 62
Citations - 2198
Craig A. Clifford is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Chemotherapy & Hemangiosarcoma. The author has an hindex of 26, co-authored 59 publications receiving 1852 citations. Previous affiliations of Craig A. Clifford include Memorial Sloan Kettering Cancer Center.
Papers
More filters
Journal ArticleDOI
Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours
Cheryl A. London,Tamra Mathie,Nicole Stingle,Craig A. Clifford,Siobhan Haney,Mary K. Klein,Linda Beaver,Kate Vickery,David M. Vail,Betsey Hershey,Susan Ettinger,Andrew Vaughan,Francisco J. Alvarez,Lorin Hillman,Mike Kiselow,Doug H. Thamm,Mary Lynn Higginbotham,Meredith Gauthier,Erika L. Krick,Brenda Phillips,Tracy Ladue,Pam Jones,Jeffery Bryan,Virginia L. Gill,Andrew Novasad,Lisa Fulton,Janet K. Carreras,C. J. McNeill,Carolyn J. Henry,Sarah Gillings +29 more
TL;DR: Preliminary evidence that toceranib exhibits CB in dogs with certain solid tumours is provided, although future prospective studies are necessary to define its true activity.
Journal ArticleDOI
Cardiac troponin I in the normal dog and cat.
TL;DR: Preliminary normal ranges of plasma cTnI in normal dogs and Cats are established for comparison to dogs and cats with myocardial injury or disease.
Journal ArticleDOI
Evaluation of palliative stenting for management of malignant urethral obstructions in dogs.
TL;DR: Transurethral placement of metallic stents was a safe and effective palliative treatment option for dogs with malignant urethral obstructions and was effective at restoring luminal patency.
Journal ArticleDOI
Treatment of Canine Hemangiosarcoma: 2000 and Beyond
TL;DR: The use of multimodality therapy incorporating innovative treatment modalities may offer the best therapeutic option for dogs affected with HSA.
Journal ArticleDOI
Cardiac Troponin I in Feline Hypertrophic Cardiomyopathy
William E. Herndon,Mark D Kittleson,Karen Sanderson,Kenneth J. Drobatz,Craig A. Clifford,Anna R. Gelzer,Anna R. Gelzer,Nuala Summerfield,Annika Linde,Meg M. Sleeper +9 more
TL;DR: The data indicate that cats with HCM have ongoing myocardial damage, which most likely explains the replacement fibrosis that is consistently identified in cats with moderate to severe HCM.